Sign Out
Active ingredient: Bevacizumab (humanised anti-VEGF monoclonal antibody).
BEVAAS Concentrate for solution for infusion 100 mg/4 mL: BEVAAS Concentrate for solution for infusion 100 mg/4 mL, each vial contains: Bevacizumab 100 mg.
BEVAAS Concentrate for solution for infusion 400 mg/16 mL: BEVAAS Concentrate for solution for infusion 400 mg/16 mL, each vial contains: Bevacizumab 400 mg.
BEVAAS is not formulated for intravitreal use (see General under PRECAUTIONS).
Excipients/Inactive Ingredients: α,α trehalose dehydrate, Dibasic sodium phosphate (Anhydrous), Monobasic sodium phosphate (monohydrate), polysorbate 20, water for injection.
